Ajanta Pharma Ltd NSE:AJANTPHARM:
AJANTA PHARMA - RECEIVES US FDA ESTABLISHMENT INSPECTION REPORT FOR PAITHAN FACILITY
AJANTA PHARMA - PAITHAN FACILITY INSPECTION CLASSIFIED AS VOLUNTARY ACTION INDICATED
Reuters
Ajanta Pharma Receives US FDA Establishment Inspection Report For Paithan Facility
- Sources
- Reuters
- Markets
- Stocks
- Active symbols
- NSE:AJANTPHARM
- Language
- English
Ajanta Pharma Ltd NSE:AJANTPHARM: